KAM
NVO

Karani Asset Management’s Novo Nordisk NVO Stock Holding History

Karani Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Sell
9,709
-1
-0% -$43 0.34% 46
2026
Q1 		$357K Sell
9,710
-19,630
-67% -$930K 0.29% 49
2025
Q4 		$1.49M Sell
29,340
-7,669
-21% -$392K 1.22% 20
2025
Q3 		$2.05M Buy
37,009
+5,884
+19% +$344K 1.64% 21
2025
Q2 		$2.15M Buy
31,125
+493
+2% +$33.5K 2.08% 19
2025
Q1 		$2.13M Buy
30,632
+6,844
+29% +$565K 2.25% 21
2024
Q4 		$2.05M Buy
+23,788
New +$2.57M 1.91% 21
2023
Q3 		$2.21M Sell
24,330
-25,330
-51% -$2.23M 3.19% 16
2023
Q2 		$4.02M Hold
49,660
– – 4.05% 12
2023
Q1 		$3.95M Sell
49,660
-11,684
-19% -$829K 4.19% 8
2022
Q4 		$4.15M Sell
61,344
-23,700
-28% -$1.39M 4.84% 5
2022
Q3 		$4.24M Buy
85,044
+1,230
+1% +$65.9K 4.3% 7
2022
Q2 		$4.67M Sell
83,814
-28,116
-25% -$1.56M 4.32% 10
2022
Q1 		$6.21M Buy
111,930
+13,810
+14% +$709K 3.36% 14
2021
Q4 		$5.5M Buy
98,120
+236
+0.2% +$12.8K 2.72% 20
2021
Q3 		$4.7M Buy
97,884
+1,460
+2% +$70.6K 2.28% 23
2021
Q2 		$4.04M Buy
96,424
+638
+0.7% +$24.7K 2.09% 23
2021
Q1 		$3.23M Buy
95,786
+3,056
+3% +$109K 1.9% 25
2020
Q4 		$3.24M Sell
92,730
-13,300
-13% -$460K 1.92% 25
2020
Q3 		$3.68M Hold
106,030
– – 2.47% 21
2020
Q2 		$3.47M Sell
106,030
-8,100
-7% -$258K 2.69% 18
2020
Q1 		$3.44M Buy
114,130
+31,330
+38% +$933K 3.67% 12
2019
Q4 		$2.4M Buy
+82,800
New +$2.29M 2.22% 16

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Karani Asset Management's NVO Position: Q2 2026 in Review

Karani Asset Management reduced its Novo Nordisk (NVO) stake by 0.01% in Q2 2026, selling an estimated $43 and leaving 9,709 shares worth $465K. The position accounts for 0.34% of the portfolio, ranked #46.

Karani Asset Management first reported a position in NVO in Q4 2019 and has held it in 23 quarters since. The position peaked at $6.21M in Q1 2022. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Karani Asset Management held 9,709 shares of Novo Nordisk worth $465K as of Q2 2026.
  • Karani Asset Management sold 1 Novo Nordisk share in Q2 2026, an estimated $43.
  • Novo Nordisk made up 0.34% of Karani Asset Management's portfolio in Q2 2026, its #46 holding.
  • Karani Asset Management first reported a position in Novo Nordisk in Q4 2019 and has held it in 23 quarters since.
  • Karani Asset Management's Novo Nordisk position peaked at $6.21M in Q1 2022.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Karani Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.